全文获取类型
收费全文 | 34586篇 |
免费 | 9250篇 |
国内免费 | 190篇 |
专业分类
耳鼻咽喉 | 335篇 |
儿科学 | 914篇 |
妇产科学 | 681篇 |
基础医学 | 6365篇 |
口腔科学 | 1150篇 |
临床医学 | 4671篇 |
内科学 | 8348篇 |
皮肤病学 | 731篇 |
神经病学 | 2892篇 |
特种医学 | 1965篇 |
外科学 | 7605篇 |
综合类 | 363篇 |
一般理论 | 15篇 |
预防医学 | 3583篇 |
眼科学 | 555篇 |
药学 | 1868篇 |
1篇 | |
中国医学 | 44篇 |
肿瘤学 | 1940篇 |
出版年
2021年 | 599篇 |
2020年 | 418篇 |
2019年 | 423篇 |
2018年 | 663篇 |
2017年 | 619篇 |
2016年 | 771篇 |
2015年 | 1123篇 |
2014年 | 1827篇 |
2013年 | 2546篇 |
2012年 | 1251篇 |
2011年 | 1179篇 |
2010年 | 1557篇 |
2009年 | 1590篇 |
2008年 | 957篇 |
2007年 | 823篇 |
2006年 | 916篇 |
2005年 | 798篇 |
2004年 | 715篇 |
2003年 | 616篇 |
2002年 | 643篇 |
2001年 | 760篇 |
2000年 | 675篇 |
1999年 | 872篇 |
1998年 | 894篇 |
1997年 | 843篇 |
1996年 | 889篇 |
1995年 | 846篇 |
1994年 | 733篇 |
1993年 | 660篇 |
1992年 | 789篇 |
1991年 | 763篇 |
1990年 | 675篇 |
1989年 | 752篇 |
1988年 | 737篇 |
1987年 | 741篇 |
1986年 | 683篇 |
1985年 | 684篇 |
1984年 | 606篇 |
1983年 | 574篇 |
1982年 | 613篇 |
1981年 | 583篇 |
1980年 | 549篇 |
1979年 | 564篇 |
1978年 | 545篇 |
1977年 | 539篇 |
1976年 | 468篇 |
1975年 | 422篇 |
1974年 | 390篇 |
1973年 | 369篇 |
1972年 | 362篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
61.
62.
63.
64.
65.
66.
Beyond C4d: Other Complement-Related Diagnostic Approaches to Antibody-Mediated Rejection 总被引:3,自引:0,他引:3
William M. Baldwin III Edward K. Kasper rea A. Zachary Barbara A. Wasowska E. Rene Rodriguez 《American journal of transplantation》2004,4(3):311-318
Complement is a multifunctional system of receptors and regulators as well as effector molecules. Both the pathogenic and diagnostic power of complement is based on the capacity of the complement system to amplify innate and adaptive immunity. This amplification is accomplished through two strategies: (1) enzymatic reactions in the complement cascade, and (2) stimulation of leukocytes, platelets and parenchymal cells through specific receptors or receptor-independent pore formation. The mechanisms by which complement mediates and modifies nonspecific inflammation, antibody-mediated injury and T-cell responses are of particular significance to the pathogenesis of transplant rejection. Understanding the mechanisms by which complement integrates the interactions of leukocytes, platelets and parenchymal cells offers opportunities to further refine the diagnosis of rejection. 相似文献
67.
Chu‐Lin Tsai MD MPH Justin A. Sobrino BS Carlos A. Camargo Jr MD DrPH 《Academic emergency medicine》2008,15(12):1275-1283
Objectives: Little is known about recent trends in U.S. emergency department (ED) visits for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) or about ED management of AECOPD. This study aimed to describe the epidemiology of ED visits for AECOPD and to evaluate concordance with guideline‐recommended care. Methods: Data were obtained from National Hospital Ambulatory Medical Care Survey (NHAMCS). ED visits for AECOPD, during 1993 to 2005, were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) codes. Concordance with guideline recommendations was evaluated using process measures. Results: Over the 13‐year study period, there was an average annual 0.6 million ED visits for AECOPD, and the visit rates for AECOPD were consistently high (3.2 per 1,000 U.S. population; Ptrend = 0.13). The trends in the use of chest radiograph, pulse oximetry, or bronchodilator remained stable (all Ptrend > 0.5). By contrast, the use of systemic corticosteroids increased from 29% in 1993–1994 to 60% in 2005, antibiotics increased from 14% to 42%, and methylxanthines decreased from 15% to <1% (all Ptrend < 0.001). Multivariable analysis showed patients in the South (vs. the Northeast) were less likely to receive systemic corticosteroids (odds ratio [OR] = 0.6; 95% confidence interval [CI] = 0.4 to 0.9). Conclusions: The high burden of ED visits for AECOPD persisted. Overall concordance with guideline‐recommended care for AECOPD was moderate, and some emergency treatments had improved over time. 相似文献
68.
69.
Eric T. Stoopler DMD res Pinto DMD Faizan Alawi DDS Sree Raghavendra DMD Ricardo Boyce Jr. DDS David Porter MD Thomas P. Sollecito DMD 《Special care in dentistry》2004,24(2):65-69
Acute myelogenous leukemia (AMU is a hematologic disorder that is characterized by an abnormal proliferation of immature myeloid cells. Granulocytic sarcomas are clusters of leukemic myeloid cells that may develop as a result of AML. Oral manifestations of AML are common and often involve enlargements of the gingiva and/or mucosal tissue from direct leukemia cell infiltration. We describe the case history of a 50-year-old man who had an ulcera-tive lesion of the oral mucosa that was determined to be a granulocytic sarcoma of AML-M0 subtype. The combination of both the subtype and clinical presentation of the leukemia makes this presentation unusual, and to the best of our knowledge, of a type that has not been previously reported in the literature. 相似文献
70.